Boehringer Ingelheim Venture Fund related stories
All articles and analysis
Optina raises $2.1m from ADDF's diagnostics acceleratorMontreal-based diagnostics company Optina has secured $2.1 million in funding from the diagnostics accelerator at the Alzheimer's Drug Discovery Foundation.
- Brainomix fetches $21.5m
Brainomix, an AI-powered medtech solutions company, has raised $21.5 million in funding.
OncoMyx lands $50m Series B led by Lumira, B CapitalThe round was led by Canada's Lumira Ventures and US-based B Capital Group with participation from LYZZ Capital and all the company's Series A investors.
Optina snags C$24.8m in DigitalDx-led Series A fundingMontreal-based Optina Diagnostics, which is focused on retinal imaging, brain health and systemic disease detection, has raised C$24.8 million in Series A financing.
- Abalos Therapeutics scores $50m Series A extension
Abalos Therapeutics, an immuno-biotherapeutics company that targets cancer cells, has secured a $50 million extension to its Series A round.
- Advent France Biotechnology launches second fund
The French life sciences firm announces a first close of its second fund at €86m ($102m).
- Nuevecor lands $24m Series A
Nuevocor, a preclinical-stage biotech company specializing in gene therapy for cardiomyopathies, has secured $24 million in Series A financing.
- Delonix Bioworks grabs $14m
Delonix Bioworks Ltd, a biotechnology company, has raised $14 million in financing.
- AgomAb Therapeutics garners $74m Series B
Drug developer AgomAb Therapeutics has secured $74 million in Series B financing.
- OMX Ventures hires VP
OMX Ventures has named Dr. Jamie Kasuboski as a vice president.